Tharani Loganathan is a Public Health Medical Specialist with a specialization in Health Economics, and a Medical Lecturer at the Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya. She is the course coordinator for the Global Health, Global Health Leadership and Law and Health modules in the Masters in Public Health (MPH) programme. She has 17 years of working experience with the Ministry of Health, Malaysia in diverse areas, notably in Primary Health Care. Dr Tharani has a medical degree from Universiti Sains Malaysia, and an MPH and DrPH from University Malaya. For her doctoral degree, Tharani conducted a comprehensive economic evaluation of rotavirus vaccines beyond cost-effectiveness, to include benefits of vaccination in improving equity and financial risk protection to inform its inclusion into the national immunization program Malaysia. She is particularly interested in health systems and policy research towards advancing health system goals of achieving Universal Health Coverage. Dr Tharani has written and spoken extensively on migrant access to healthcare, including the healthcare financing and social protection policies for migrant workers in Malaysia. Currently, Dr Tharani is investigating the provisions for educational access for non-citizen children in Malaysia. Tharani Loganathan is an Atlantic Fellow for Health Equity in South East Asia.  

Dr. UZAIR ISHTIAQ received master’s degree in Computer Science from NUCES Islamabad, Pakistan, and the Ph.D. degree Faculty of Computer Science and Information Technology, Universiti Malaya, Malaysia. He worked as a Lecturer at COMSATS University Islamabad for more than 10 years and has been Senior Lecturer with the Department of Artificial Intelligence, FCSIT, Universiti Malaya, Malaysia, since 2025. He has published several articles in academic journals indexed in ISI and Scopus.

Dr. Nurshamimi was awarded a Malaysia-Imperial Doctoral Programme to study HPV regulation at the Department of Virology, St. Mary’s Campus, Imperial College London, upon graduating with an M.Med.Sc from the University of Malaya in 2008. She joined the Department of Molecular Medicine as a Senior Lecturer in 2014 and was promoted to Associate Professor in 2021. She was a three-time travel award winner for attending HKU-Pasteur workshops at the University of Hong Kong. She also received travel awards from the International Papillomavirus Society in 2017 for the HPV conference in South Africa and a travel award from the EMBL Advanced Training Centre Corporate Partnership Program Fellowship in 2015 for the EMBO Conference in Heidelberg, Germany. She is also a member of the European Association for Cancer Research (EACR) and the European Society for Virology. In 2020, she won the Bill & Melinda Gates Foundation Young Investigator Award for her work on the Chikungunya virus, and in 2022, she received a travel award from Keystone Symposia, Global Health Travel Award, USA. In 2024, she was selected by Cold Spring Harbor Laboratory, USA, to present her work entitled "Morindone from Morinda citrifolia—A promising agent targeting DNA replication and key mutations in colorectal cancer" at their conference 'Mechanisms and Models of Cancer'. Dr. Nurshamimi also holds several patents in the field of anti-aging and colorectal cancer. Her current research is geared toward phase 1 clinical trials for diabetic foot ulcer treatment and investigating potential leads for colorectal cancer targets. She is an Ambassador for Bentham Science Publisher, one of the most renowned ISI publishers in the world. Currently, she is a principal investigator for research projects on colorectal cancer, Zika and dengue viruses, anti-aging, and diabetic foot ulcers.